Psoriatic Skin Lesions after Apalutamide Treatment

Authors

  • Fumi Miyagawa Nara Medical University
  • Nobuya Akioka
  • Noriko Yoshida
  • Kohei Ogawa
  • Hideo Asada

DOI:

https://doi.org/10.2340/actadv.v102.858

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, et al. Apalutamide treatment and metastasis-free survival in prostate cancer. N Engl J Med 2018; 378: 1408-1418.

https://doi.org/10.1056/NEJMoa1715546

Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R et al. Apalutamide for metastatic, castration-sensitive prostate cancer. N Engl J Med 2019; 381: 13-24.

https://doi.org/10.1056/NEJMoa1903307

Schwarz W, Schell H, Hornstein OP. Testosterone serum levels in male psoriatics. Arch Dermatol Res 1981; 270: 377-379.

https://doi.org/10.1007/BF00403945

Cemil BC, Cengiz FP, Atas H, Ozturk G, Canpolat F. Sex hormones in male psoriasis patients and their correlation with the Psoriasis Area and Severity Index. J Dermatol 2015; 42: 500-503.

https://doi.org/10.1111/1346-8138.12803

Allam JP, Bunzek C, Schnell L, Heltzel M, Weckbecker L, Wilsmann-Theis D et al. Low serum testosterone levels in male psoriasis patients correlate with disease severity. Eur J Dermatol 2019; 29: 375-382.

https://doi.org/10.1684/ejd.2019.3605

Rathkopf DE, Scher HI. Apalutamide for the treatment of prostate cancer. Expert Rev Anticancer Ther 2018; 18: 823-836.

https://doi.org/10.1080/14737140.2018.1503954

Shima K, Nomura T, Yamada Y, Usui S, Kobayashi T, Kabashima K. Maculopapular-type drug eruptions caused by apalutamide: case series and a review of the literature. J Eur Acad Dermatol Venereol 2022; 36: e113-e115.

https://doi.org/10.1111/jdv.17657

Downloads

Published

2022-02-28

How to Cite

Miyagawa, F., Akioka, N., Yoshida, N., Ogawa, K., & Asada, H. (2022). Psoriatic Skin Lesions after Apalutamide Treatment. Acta Dermato-Venereologica, 102, adv00659. https://doi.org/10.2340/actadv.v102.858

Issue

Section

Short Communication

Categories